X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1948) 1948
humans (1402) 1402
male (1319) 1319
animals (903) 903
anilides - pharmacology (817) 817
anilides - administration & dosage (680) 680
anilides - therapeutic use (664) 664
female (559) 559
middle aged (545) 545
aged (503) 503
rats (372) 372
mice (370) 370
prostatic neoplasms - drug therapy (361) 361
adult (319) 319
pharmacology & pharmacy (319) 319
anilides - adverse effects (316) 316
abridged index medicus (302) 302
oncology (297) 297
prostate cancer (257) 257
nitriles (233) 233
cancer (231) 231
tosyl compounds (231) 231
dose-response relationship, drug (206) 206
treatment outcome (205) 205
aged, 80 and over (202) 202
urology & nephrology (192) 192
antineoplastic agents - therapeutic use (184) 184
pyridines - therapeutic use (184) 184
care and treatment (181) 181
time factors (180) 180
prostatic neoplasms - pathology (175) 175
administration, oral (173) 173
androgen antagonists - therapeutic use (173) 173
anilides - pharmacokinetics (167) 167
cell line, tumor (158) 158
bicalutamide (154) 154
androgen antagonists - administration & dosage (153) 153
encainide (145) 145
drug therapy, combination (140) 140
nitriles - administration & dosage (139) 139
tosyl compounds - administration & dosage (137) 137
expression (130) 130
disease models, animal (128) 128
signal transduction - drug effects (127) 127
research (124) 124
antineoplastic agents - administration & dosage (122) 122
pyridines - administration & dosage (121) 121
analysis (120) 120
carcinoma (119) 119
pyridines - pharmacology (119) 119
ppar gamma - metabolism (118) 118
antineoplastic combined chemotherapy protocols - therapeutic use (116) 116
ppar gamma - antagonists & inhibitors (115) 115
therapy (115) 115
article (112) 112
drug therapy (110) 110
prostate-specific antigen - blood (108) 108
rats, sprague-dawley (104) 104
clinical trials as topic (103) 103
health aspects (103) 103
antineoplastic agents - adverse effects (102) 102
metastasis (101) 101
pyridines - adverse effects (96) 96
carcinoma, basal cell - drug therapy (95) 95
cell proliferation - drug effects (94) 94
antineoplastic agents - pharmacology (93) 93
prostatic neoplasms - blood (93) 93
androgen antagonists - pharmacology (91) 91
hedgehog proteins - antagonists & inhibitors (91) 91
vismodegib (91) 91
activation (90) 90
anilides - chemistry (90) 90
neurosciences (90) 90
skin neoplasms - drug therapy (89) 89
uracil - analogs & derivatives (89) 89
biochemistry & molecular biology (88) 88
anilides - metabolism (87) 87
medicine & public health (87) 87
antineoplastic agents, hormonal - therapeutic use (86) 86
dogs (86) 86
follow-up studies (85) 85
hepatitis c, chronic - drug therapy (84) 84
anti-arrhythmia agents - therapeutic use (83) 83
endocrinology & metabolism (83) 83
mice, inbred c57bl (83) 83
nitriles - therapeutic use (83) 83
flutamide (82) 82
tumors (81) 81
cell biology (80) 80
tosyl compounds - therapeutic use (80) 80
anilides - blood (79) 79
drug administration schedule (79) 79
neoplasm staging (79) 79
pharmacokinetics (79) 79
rats, wistar (79) 79
apoptosis (78) 78
chemotherapy (78) 78
electrocardiography (77) 77
cells, cultured (76) 76
dosage and administration (76) 76
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1964) 1964
German (28) 28
Russian (17) 17
Japanese (16) 16
Italian (15) 15
French (9) 9
Chinese (7) 7
Spanish (4) 4
Polish (3) 3
Czech (2) 2
Norwegian (2) 2
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 3, pp. 457 - 471.e5
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 6, pp. 1138 - 1148
Graphical abstract 
Gastroenterology and Hepatology | Antiviral agents | Ombitasvir | Ritonavir | Ledipasvir | Real-world | Genotype 1 | Paritaprevir | Sustained virologic response | Hepatitis C, Chronic | Sofosbuvir | Dasabuvir | Randomized controlled trials | PLUS RIBAVIRIN | VIRUS-INFECTION | CHRONIC HEPATITIS-C | SUSTAINED VIROLOGICAL RESPONSE | ALL-CAUSE MORTALITY | Chronic | HEPATOCELLULAR-CARCINOMA | TREATMENT-EXPERIENCED PATIENTS | Hepatitis C | GASTROENTEROLOGY & HEPATOLOGY | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Neoplasm Recurrence, Local - etiology | Liver Neoplasms - etiology | Young Adult | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Drug Therapy, Combination | Glomerular Filtration Rate | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Spain | Anilides - administration & dosage | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Sulfonamides - administration & dosage | Cohort Studies | Uracil - analogs & derivatives | Genetic aspects | Safety and security measures | Hepatitis C virus | Clinical trials | Chronic infection | Data processing | Hepatocellular carcinoma | Multivariate analysis | Patients | Clinical outcomes | Ribavirin | Genotype & phenotype | Cohort analysis | Fibrosis | Safety | Drug therapy | Antiviral drugs | Genotypes | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2017, Volume 64, Issue 12, pp. 1711 - 1720
Background. Large cohorts are needed to assess human immunodeficiency virus (HIV)/hepatitis C virus (HCV) real-world treatment outcomes. We examined the... 
real-world | HCV | HIV | DAA | INFECTIOUS DISEASES | HIV/HCV | LEDIPASVIR-SOFOSBUVIR | CHRONIC HEPATITIS-C | MICROBIOLOGY | COINFECTED INDIVIDUALS | IMMUNOLOGY | INFECTION | COHORT | Uridine Monophosphate - administration & dosage | Anilides - therapeutic use | Hepatitis C - drug therapy | Coinfection - drug therapy | Veterans | Humans | Middle Aged | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | Carbamates - administration & dosage | Practice Patterns, Physicians | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Female | Fluorenes - administration & dosage | Hepatitis C - complications | Registries | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Administration, Oral | Antiviral Agents - therapeutic use | HIV Infections - virology | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Antiviral Agents - administration & dosage | Coinfection - virology | Macrocyclic Compounds - therapeutic use | Anilides - administration & dosage | Sofosbuvir - administration & dosage | Uridine Monophosphate - analogs & derivatives | HIV Infections - complications | Hepatitis C - virology | HIV Infections - drug therapy | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Carbamates - therapeutic use | Cohort Studies | Antiviral agents | Care and treatment | Dosage and administration | Hepatitis C | HIV infection | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, pp. 1223 - 1231
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 7, pp. 1590 - 1598
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1314 - 1325
Despite theoretical benefits of intermittent as compared with continuous androgen-deprivation therapy in patients with metastatic prostate cancer, intermittent... 
MEDICINE, GENERAL & INTERNAL | THERAPY | CLINICAL-TRIAL | FLUTAMIDE | QUALITY-OF-LIFE | SUPPRESSION | CARCINOMA | LEUPROLIDE | Confidence Intervals | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis - drug therapy | Penile Erection - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Prostatic Neoplasms - drug therapy | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Tosyl Compounds - administration & dosage | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Anilides - administration & dosage | Survival Analysis | Quality of Life | Aged | Androgen Antagonists - administration & dosage | Nitriles - adverse effects | Usage | Care and treatment | Patient outcomes | Androgen suppression therapy | Drug therapy | Prostate cancer | Methods | Cancer | Statistical analysis | Mental disorders | Prostate-specific antigen | Clinical trials | Patients | Survival | Quality of life | Metastases | Androgens | Castration | Stem cells | Luteinizing hormone | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 1, pp. 20 - 29
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/2016, Volume 44, Issue 9, pp. 946 - 956
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 64, Issue 1, pp. 19 - 28
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 320 - 327
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 05/2015, Volume 15, Issue 5, pp. 1313 - 1322
The authors describe the drug–drug interaction profile of the he patitis C direct‐acting antiviral agents ABT‐450, ombitasvir, and dasabuvir with cyclosporine... 
infectious disease | clinical research/practice | pharmacology | calcineurin inhibitor: cyclosporine A (CsA) | pharmacokinetics/pharmacodynamics | immunosuppressant | infection and infectious agents | calcineurin inhibitor: tacrolimus | liver transplantation/hepatology | viral: hepatitis C | SURGERY | ABT-450/R-OMBITASVIR | LIVER-TRANSPLANTATION | EFFICACY | DRUG-INTERACTIONS | TRANSPORTERS | INFECTION | HCV | RIBAVIRIN | INHIBITOR | HEPATITIS-C | TRANSPLANTATION | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Area Under Curve | Humans | Middle Aged | Male | Anilides - pharmacokinetics | Carbamates - administration & dosage | Healthy Volunteers | Carbamates - pharmacokinetics | Young Adult | Uracil - administration & dosage | Cyclosporine - pharmacokinetics | Adult | Female | Tacrolimus - administration & dosage | Hepacivirus - drug effects | Drug Administration Schedule | Macrocyclic Compounds - pharmacokinetics | Tacrolimus - pharmacokinetics | Antiviral Agents - administration & dosage | Sulfonamides - pharmacokinetics | Anilides - administration & dosage | Adolescent | Cyclosporine - administration & dosage | Macrocyclic Compounds - administration & dosage | Uracil - pharmacokinetics | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Dosage and administration | Liver diseases | Drug therapy, Combination | Tacrolimus | Hepatitis C virus | Hepatitis C | Hepatitis | Medical research | Drug dosages | Index Medicus | practice | pharmacodynamics | hepatology | clinical research | pharmacokinetics | Original | liver transplantation
Journal Article